Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
Condition: Triple Negative Breast Cancer Interventions: Drug: Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide; Drug: paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide Sponsor: Hebei Medical University Fourth Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials